{"disease":{"id":"idiopathic-pulmonary-fibrosis-ipf","name":"idiopathic pulmonary fibrosis ipf"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07178392","title":"Disease-syndrome Characteristics of IPF","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":2864,"lead_sponsor_name":"Henan University of Traditional Chinese Medicine","has_results":false},{"nct_id":"NCT02758808","title":"Pulmonary Fibrosis Foundation Patient Registry","phase":"","overall_status":"COMPLETED","enrollment_count":2004,"lead_sponsor_name":"Pulmonary Fibrosis Foundation","has_results":false},{"nct_id":"NCT07162870","title":"Idiopathic Pulmonary Fibrosis Cohort of TCM","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Henan University of Traditional Chinese Medicine","has_results":false},{"nct_id":"NCT03478553","title":"The Genetics of Pulmonary Fibrosis","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT04263727","title":"A Study of Patients With Chronic Disease","phase":"","overall_status":"TERMINATED","enrollment_count":579,"lead_sponsor_name":"Target PharmaSolutions, Inc.","has_results":false},{"nct_id":"NCT07464912","title":"A Adaptive Design Clinical Trial to Evaluate the Efficacy and Safety of TDI01 Suspension in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":508,"lead_sponsor_name":"Beijing Tide Pharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT07082842","title":"Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":472,"lead_sponsor_name":"Sunshine Lake Pharma Co., Ltd.","has_results":false},{"nct_id":"NCT06914713","title":"Jin-shui Huan-xian Formula for Retarding the Decline of Pulmonary Function in IPF","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":384,"lead_sponsor_name":"Henan University of Traditional Chinese Medicine","has_results":false},{"nct_id":"NCT06951217","title":"An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":340,"lead_sponsor_name":"Avalyn Pharma Inc.","has_results":false},{"nct_id":"NCT06922916","title":"Perioperative Risk Factors Related to the Prognosis of Lung Transplantation: A Retrospective Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":250,"lead_sponsor_name":"Zhejiang University","has_results":false},{"nct_id":"NCT03832946","title":"A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":172,"lead_sponsor_name":"Galecto Biotech AB","has_results":true},{"nct_id":"NCT07486206","title":"Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":152,"lead_sponsor_name":"Hospital de Granollers","has_results":false},{"nct_id":"NCT06650774","title":"Comparison of the Efficacy of Pirfenidone and Nintedanipine in Pulmonary Fibrosis","phase":"","overall_status":"COMPLETED","enrollment_count":152,"lead_sponsor_name":"Karadeniz Technical University","has_results":false},{"nct_id":"NCT07179562","title":"Motivational Interviewing Program on the Self-Care in Idiopathic Pulmonary Fibrosis","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":124,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT06909409","title":"D Vitamin and Alveolar Macrophages in Idiopathic Pulmonal Fibrosis","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT06968845","title":"A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Rein Therapeutics","has_results":false},{"nct_id":"NCT07019090","title":"Long-term Safety and Efficacy Study of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis (IPF)","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Haisco Pharmaceutical Group Co., Ltd.","has_results":false},{"nct_id":"NCT07466420","title":"Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases.","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Katerina M. Antoniou","has_results":false},{"nct_id":"NCT07447102","title":"Phase II Clinical Study of BC006 in Patients With Idiopathic Pulmonary Fibrosis","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":96,"lead_sponsor_name":"Dragonboat Biopharmaceutical Company Limited","has_results":false},{"nct_id":"NCT07482917","title":"Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":92,"lead_sponsor_name":"Hospital de Granollers","has_results":false},{"nct_id":"NCT03650075","title":"To Determine Safety and Tolerability of MG-S-2525 and to Evaluate Its PK Profile in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":81,"lead_sponsor_name":"Metagone Biotech Inc.","has_results":false},{"nct_id":"NCT04589260","title":"TD-1058 First-In-Human Study in Healthy Subjects and Subjects With Idiopathic Pulmonary Fibrosis","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":72,"lead_sponsor_name":"Theravance Biopharma","has_results":false},{"nct_id":"NCT05938920","title":"Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis (IPF)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":71,"lead_sponsor_name":"InSilico Medicine Hong Kong Limited","has_results":true},{"nct_id":"NCT07131150","title":"Menstrual Blood-Derived Mesenchymal Stem Cell Injection (SC01009) in the Treatment of Idiopathic Pulmonary Fibrosis","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":66,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT07178197","title":"Sarcopenia in Patients With Idiopathic Pulmonary Fibrosis","phase":"","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Mersin University","has_results":false},{"nct_id":"NCT06636487","title":"Expand Pulmonary Rehabilitation to Other Chronic Respiratory Diseases Than COPD","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":50,"lead_sponsor_name":"Copenhagen University Hospital, Hvidovre","has_results":false},{"nct_id":"NCT04598919","title":"Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":49,"lead_sponsor_name":"National Jewish Health","has_results":false},{"nct_id":"NCT07121413","title":"A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SV001 in Patients With Idiopathic Pulmonary Fibrosis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":48,"lead_sponsor_name":"Shanghai Synvida Biotechnology Co.,Ltd.","has_results":false},{"nct_id":"NCT01371305","title":"STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"Biogen","has_results":true},{"nct_id":"NCT05975983","title":"Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"InSilico Medicine Hong Kong Limited","has_results":false},{"nct_id":"NCT03619616","title":"Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose of ZSP1603 in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Guangdong Zhongsheng Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT06331624","title":"Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"GRI Bio Operations, Inc.","has_results":false},{"nct_id":"NCT06756230","title":"Downhill Walking in IPF","phase":"NA","overall_status":"RECRUITING","enrollment_count":34,"lead_sponsor_name":"Saglik Bilimleri Universitesi","has_results":false},{"nct_id":"NCT06747923","title":"SB17170 Phase 2 Trial in IPF Patients","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"SPARK Biopharma","has_results":false},{"nct_id":"NCT05353556","title":"Effects of Home-based Inspiratory Muscle Training in Patients With IPF","phase":"NA","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Dokuz Eylul University","has_results":false},{"nct_id":"NCT02874989","title":"Targeting Pro-Inflammatory Cells in Idiopathic Pulmonary Fibrosis: a Human Trial","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":false},{"nct_id":"NCT07344558","title":"A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients With Idiopathic Pulmonary Fibrosis","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"Mannkind Corporation","has_results":false},{"nct_id":"NCT03981094","title":"A Study of the Pharmacokinetic Interaction Between Pirfenidone and BMS-986278 in Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT07119099","title":"The relatıonshıp Between Upper Extremity Exercise Test and Exercise Capacity ın patıents wıth Idiopathic Pulmonary Fibrosis","phase":"","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"Marmara University","has_results":false},{"nct_id":"NCT04497831","title":"Morphine for Dyspnea in Pulmonary Fibrosis","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Medical University of Gdansk","has_results":false},{"nct_id":"NCT06683612","title":"PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPF","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Contineum Therapeutics","has_results":false},{"nct_id":"NCT05119972","title":"Tolerability, Pharmacokinetics and Efficacy of ZSP1603 in Patients With Idiopathic Pulmonary Fibrosis （IPF）","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Guangdong Raynovent Biotech Co., Ltd","has_results":false},{"nct_id":"NCT02503657","title":"Safety, Tolerability, and Efficacy of MN-001 (Tipelukast) in Patients With Idiopathic Pulmonary Fibrosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"MediciNova","has_results":true},{"nct_id":"NCT04069143","title":"A Study to Evaluate the Safety, Tolerability, Kinetics and Repeatability of 18F-BMS-986327","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT07359963","title":"Treatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND007 Cell Therapy","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":12,"lead_sponsor_name":"Regend Therapeutics","has_results":false},{"nct_id":"NCT02013700","title":"Allogeneic Human Cells (hMSC)in Patients With Idiopathic Pulmonary Fibrosis Via Intravenous Delivery (AETHER)","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":9,"lead_sponsor_name":"Joshua M Hare","has_results":false},{"nct_id":"NCT07515066","title":"Safety and Efficacy of Nebulized 3D-cultured Human Placental Mesenchymal Stem Cell-derived Extracellular Vesicles (hPMSC-EVs) for Idiopathic Pulmonary Fibrosis","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":9,"lead_sponsor_name":"Huan Ye","has_results":false},{"nct_id":"NCT07329959","title":"CAR-DC for End-Stage IPF","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":8,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false}],"total":48},"guidelines":[],"source":"Drug Landscape verified database"}